Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Vainchenker

Showing results (1-10 of 266) with videos related to

Pageof 27
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2011
Myeloproliferative neoplasms: molecular pathophysiology, essential clinical understanding, and treatment strategiesAyalew Tefferi, William Vainchenker
Blood|December 29, 2016
Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasmsWilliam Vainchenker, Robert Kralovics
Blood|January 21, 2017
P53 deletion and NrasG12D cooperate for AMLWilliam Vainchenker, Isabelle Plo
Blood|January 21, 2021
IFN: Jekyll and HydeIsabelle Plo, William Vainchenker
Blood|January 10, 2015
TET2 loss, a rescue of JAK2V617F HSCsWilliam Vainchenker, Isabelle Plo
Blood|July 2, 2016
EZH2: a molecular switch of the MPN phenotypeWilliam Vainchenker, Isabelle Plo
Platelets|September 24, 2019
Megakaryocyte polyploidization: role in platelet productionWilliam Vainchenker, Hana Raslova
Blood|December 23, 2017
CK2: a key regulator of thrombopoiesisWilliam Vainchenker, Hana Raslova
Medecine Sciences : M/S|May 10, 2008
[From giant to micro: a platelet story]Najet Debili, William Vainchenker
Clinical Lymphoma & Myeloma|September 26, 2009
Molecular and genetic bases of myeloproliferative disorders: questions and perspectivesIsabelle Plo, William Vainchenker
Pageof 27

Showing results (1-10 of 266) with videos related to

Sort By:
Pageof 27
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2011
Myeloproliferative neoplasms: molecular pathophysiology, essential clinical understanding, and treatment strategiesAyalew Tefferi, William Vainchenker
Blood|December 29, 2016
Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasmsWilliam Vainchenker, Robert Kralovics
Blood|January 21, 2017
P53 deletion and NrasG12D cooperate for AMLWilliam Vainchenker, Isabelle Plo
Blood|January 21, 2021
IFN: Jekyll and HydeIsabelle Plo, William Vainchenker
Blood|January 10, 2015
TET2 loss, a rescue of JAK2V617F HSCsWilliam Vainchenker, Isabelle Plo
Blood|July 2, 2016
EZH2: a molecular switch of the MPN phenotypeWilliam Vainchenker, Isabelle Plo
Platelets|September 24, 2019
Megakaryocyte polyploidization: role in platelet productionWilliam Vainchenker, Hana Raslova
Blood|December 23, 2017
CK2: a key regulator of thrombopoiesisWilliam Vainchenker, Hana Raslova
Medecine Sciences : M/S|May 10, 2008
[From giant to micro: a platelet story]Najet Debili, William Vainchenker
Clinical Lymphoma & Myeloma|September 26, 2009
Molecular and genetic bases of myeloproliferative disorders: questions and perspectivesIsabelle Plo, William Vainchenker
Pageof 27